1. Home
  2. MITQ vs INBS Comparison

MITQ vs INBS Comparison

Compare MITQ & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moving iMage Technologies Inc.

MITQ

Moving iMage Technologies Inc.

N/A

Current Price

$0.56

Market Cap

6.2M

ML Signal

N/A

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

SELL

Current Price

$1.59

Market Cap

6.5M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MITQ
INBS
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.5M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
MITQ
INBS
Price
$0.56
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 163.5K
37.4K
Earning Date
09-28-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 70.00
N/A
EPS
★ N/A
N/A
Revenue
★ $20,139,000.00
$1,980,484.00
Revenue This Year
N/A
$44.72
Revenue Next Year
N/A
$44.26
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.42
$0.54
52 Week High
$1.12
$24.90

Technical Indicators

Market Signals
Indicator
MITQ
INBS
Relative Strength Index (RSI) 43.76 30.19
Support Level $0.53 $1.52
Resistance Level $0.64 $2.45
Average True Range (ATR) 0.06 0.14
MACD -0.01 -0.02
Stochastic Oscillator 27.35 3.81

Price Performance

Historical Comparison
MITQ
INBS

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

Share on Social Networks: